Retatrutide (LY3437943) is a synthetic peptide composed of 39 amino acids, engineered with a C20 fatty diacid moiety that extends its half-life to approximately six days and supports once-weekly administration in research settings
As a registered dietitian, SaVanna has worked with pregnant and postpartum women, infants and children, people with c
While treatment decisions remain grounded in clinical need and professional guidance, growing awareness and adoption mean that patients are increasingly considering factors such as brand, value, efficacy, convenience and trust
Iron supplements : Several found relief from anaemia symptoms by boosting iron intake
The defining distinction is receptor coverage: Semaglutide: Single-pathway agonist GLP-1 only Tirzepatide: Dual-pathway agonist GLP-1 + GIP Retatrutide: Triple-pathway agonist GLP-1 + GIP + glucagon The addition of glucagon receptor activity is the variable most commonly studied in models examining energy expenditure and hepatic lipid behaviour, which has positioned retatrutide as the focal compound in current metabolic peptide literature
